3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
69
Carcinoma, Intraductal, Noninfiltrating
9
Breast Carcinoma In Situ
6
Breast Neoplasms, Male
5
Neoplasms
3
Neoplasm Metastasis
3
Urinary Bladder Neoplasms
2
Inflammatory Breast Neoplasms
2
Sleep Wake Disorders
1
Risk Reduction Behavior
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer
1
Mastodynia
1
Glioma
1
Fibrocystic Breast Disease
1
Fibroadenoma
1
Fatigue
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Disease Progression
1
Desmoid Tumors
1
Cystic Fibrosis
1
Cystadenocarcinoma, Serous
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Lobular
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Cancer Metastatic
1
Interventions
Mitotane
4
Cisplatin
3
pembrolizumab
2
cixutumumab
2
Etoposide
2
Doxorubicin
2
Dichlorodiphenyldichloroethane
2
sodium thiosulfate
1
relacorilant
1
pegfilgrastim
1
milademetan
1
gossypol acetic acid
1
cabozantinib
1
avelumab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Sunitinib
1
Streptozocin
1
Platinum
1
Nivolumab
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Fentanyl
1
Ethane
1
Cytoreduction Surgical Procedures
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adrenocortical Carcinoma
×
Tamoxifen
×
Clear all
No trials found.